recent
find
regard
cellular
biolog
immunolog
also
known
tetherin
indic
function
could
exploit
univers
replic
inhibitor
envelop
respiratori
virus
eg
influenza
respiratori
syncyti
viru
etc
inhibit
viral
replic
prevent
viru
bud
plasma
membran
induc
antivir
state
cell
adjac
infect
via
uniqu
inflammatori
signal
mechan
review
present
first
comprehens
summari
current
known
antivir
function
respiratori
virus
virus
construct
countermeasur
antagon
function
might
target
develop
therapi
treat
respiratori
viru
infect
author
address
current
gap
knowledg
includ
need
mechanist
understand
antagon
respiratori
virus
bridg
achiev
goal
respiratori
virus
repres
enorm
worldwid
health
burden
common
caus
respiratori
tract
infect
third
lead
caus
death
worldwid
deadli
communic
diseas
current
option
prevent
clear
respiratori
viru
infect
limit
notabl
shortcom
exampl
effect
vaccin
season
influenza
viru
iav
usual
hover
around
often
delay
strain
identif
vaccin
product
current
vaccin
respiratori
syncyti
viru
rsv
antivir
drug
present
approv
treat
respiratori
viru
infect
iav
neuraminidas
inhibitor
individu
suffer
chronic
airway
diseas
asthma
chronic
obstruct
pulmonari
diseas
copd
respiratori
viru
infect
caus
debilit
potenti
deadli
exacerb
addit
acut
diseas
frequent
sever
respiratori
viral
infect
youth
implic
detriment
airway
remodel
develop
chronic
diseas
asthma
copd
adulthood
thu
current
unmet
need
develop
new
antivir
treat
respiratori
viru
infect
major
respiratori
virus
rna
virus
initi
infect
epitheli
cell
nasal
passag
airway
virus
primarili
infect
minim
infecti
dose
util
host
cell
machineri
replic
produc
new
virion
infect
cell
eventu
caus
epitheli
cell
death
airway
remodel
effici
amplif
includ
viru
releas
infect
new
cell
obligatori
viru
surviv
diseas
pathogenesi
subvert
process
host
cell
encod
sever
interferon
ifn
induc
antivir
factor
constitut
potent
batteri
innat
immun
defens
antivir
factor
interfer
variou
step
viral
replic
pathway
aid
clearanc
comprehens
mechanist
understand
host
antivir
factor
function
could
potenti
exploit
develop
new
treatment
limit
diseas
caus
respiratori
virus
essay
focu
function
one
particularli
prolif
host
antivir
factor
call
bone
marrow
stromal
antigen
also
known
tetherin
examin
whether
could
target
inhibit
replic
respiratori
virus
aid
clearanc
demonstr
broadspectrum
antivir
activ
numer
envelop
virus
respons
virus
evolv
function
antagon
shown
restrict
nonenvelop
virus
thu
discuss
focu
common
envelop
respiratori
virus
caus
diseas
human
eg
iav
rsv
parainfluenza
viru
piv
metapneumoviru
mpv
coronavirus
cov
mous
model
sendai
viru
sev
discuss
common
nonenvelop
respiratori
virus
eg
rhinoviru
rv
enteroviru
review
known
regard
regul
express
structur
function
mechan
antivir
function
mode
antagon
viral
protein
modul
signal
immunolog
cellular
function
pay
special
attent
set
airway
epitheli
cell
respiratori
virus
follow
viral
infect
order
optim
inhibit
respiratori
viru
replic
would
need
express
epitheli
cell
airway
mucos
surfac
number
signal
pathway
demonstr
induc
express
promot
region
contain
consensu
site
transcript
factor
accordingli
interferon
ifn
three
class
ie
induc
express
numer
cell
type
mice
express
appear
limit
plasmacytoid
dendrit
cell
upregul
cell
type
interferon
induc
secret
respons
viral
infect
howev
upregul
limit
ifn
signal
number
ifnindepend
stimul
also
report
exampl
potent
induc
stimul
induc
express
absenc
ifn
contrast
despit
appar
presenc
bind
site
promot
region
littl
impact
express
level
express
downmodul
respons
ifni
gener
conserv
cell
express
increas
airway
part
antivir
respons
howev
differ
observ
whether
express
induc
airway
epitheli
cell
cultur
primari
mous
airway
epitheli
cell
mous
airway
cell
line
express
induc
modestli
increas
h
iav
infect
contrast
observ
increas
express
vivo
mous
airway
epitheli
cell
follow
sev
iav
infect
unpublish
data
express
upregul
human
airway
cell
line
follow
viral
infect
ifni
product
overal
observ
suggest
express
airway
mucos
epithelia
respons
viral
infect
antivir
function
first
report
demonstr
inhibit
releas
viral
particl
defici
viral
membran
protein
vpu
inhibit
viral
replic
prevent
releas
viral
progeni
infect
cell
lead
subsequ
intern
degrad
sinc
shown
potent
inhibit
sever
envelop
virus
bud
plasma
membran
due
pressur
virus
develop
antagonist
strategi
block
function
viral
tether
function
typic
demonstr
assay
use
mutant
virus
defici
protein
vpudefici
viruslik
particl
vlp
type
studi
shown
restrict
bud
vlp
mutant
virus
follow
famili
retrovirus
alpha
beta
delta
lenti
spuma
arenavirus
lassa
machupo
herpesvirus
kshv
filovirus
ebola
marburg
rhabdovirus
vesicular
stomat
paramyxovirus
nipah
flavivirus
hepat
c
shown
effect
inhibit
bud
intact
infecti
virus
includ
lassa
machupo
arenavirus
vesicular
stomat
rhabdoviru
restrict
infecti
virus
ebola
marburg
cowpox
rift
valley
fever
bunyaviru
observ
demonstr
inhibit
bud
broad
spectrum
envelop
virus
suggest
might
inhibit
releas
envelop
respiratori
virus
infect
epitheli
cell
recent
studi
investig
potenti
restrict
bud
respiratori
virus
tabl
iav
result
appear
depend
viru
strain
cell
type
use
group
report
restrict
iav
releas
other
report
inhibit
releas
iav
vlp
partial
restrict
infecti
viru
observ
appear
depend
iavencod
antagonist
ident
effect
may
strain
depend
discuss
section
also
partial
restrict
human
pathogen
sar
restrict
enhanc
delet
viral
antagonist
also
restrict
anim
model
respiratori
viru
sev
interestingli
seem
inhibit
prrsv
thu
appear
restrict
number
envelop
respiratori
virus
vitro
abil
hinder
encod
viral
antagonist
discuss
section
structur
organ
highli
uniqu
among
mammalian
protein
type
ii
transmembran
protein
consist
short
ntermin
cytoplasm
tail
ct
singl
transmembran
region
tm
ectodomain
ed
second
membran
anchora
ctermin
glycosylphosphotidylinositol
gpi
figur
sequenc
analysi
suggest
dualanchor
topolog
found
one
protein
human
genom
special
form
prion
protein
structur
featur
import
antivir
function
delet
either
one
membran
anchor
tm
gpi
ablat
abil
restrict
viral
bud
addit
membran
anchor
requir
viral
tether
gpianchor
requir
cellular
traffick
sequest
er
cell
defect
gpibiosynthesi
pathway
gpianchor
enrich
lipid
raft
enhanc
antivir
activ
sinc
prefer
site
bud
mani
envelop
virus
matur
recycl
plasma
membran
endosom
transgolgi
network
tgn
despit
local
lipid
raft
intern
via
clathrindepend
endocytosi
mediat
evolutionarili
conserv
yxi
motif
ct
recruit
adaptor
ectodomain
numer
structur
featur
requir
optim
antivir
function
figur
ectodomain
span
two
membran
anchor
form
coiledcoil
parallel
dimer
contain
three
interdim
disulfid
resembl
molecular
rope
span
roughli
ectodomain
coiledcoil
uniqu
contain
conserv
pattern
residu
dimer
interfac
destabil
pack
caus
ectodomain
act
less
other
report
inhibit
iav
vlp
releas
depend
neuraminidas
sequenc
other
report
inhibit
infecti
iav
iav
vlp
enhanc
loss
iav
broadli
target
isg
express
rna
level
may
partial
inhibit
lower
express
paramyxoviru
inhibit
releas
sendai
sev
paramyxoviru
inhibit
sev
releas
pm
sar
cov
coronaviru
inhibit
sar
releas
pm
strongli
inhibit
releas
pm
human
cov
coronaviru
inhibit
releas
pm
porcin
reproduct
respiratori
syndrom
viru
prrsv
arteriviru
prrsv
e
protein
interact
yeast
twohybrid
misloc
surfac
inhibit
prrsv
cov
coronaviru
piv
parainfluenza
viru
pm
plasma
membran
sar
sever
acut
respiratori
syndrom
sar
delet
figur
structur
mechan
viral
tether
crystal
structur
mous
ectodomain
structur
featur
highlight
nlink
glycosyl
site
green
box
disulfid
bond
blue
box
transmembran
domain
gpi
anchor
ntermin
cytoplasm
tail
shown
cartoon
black
label
correspond
mous
sequenc
featur
correspond
residu
valu
human
shown
red
ital
b
direct
tether
model
mediat
inhibit
viral
bud
parallel
dimer
incorpor
one
set
membran
anchor
viral
membran
host
membran
threeto
fivefold
prefer
incorpor
gpianchor
viral
membran
left
versu
orient
right
c
dimer
assembl
creat
crystallograph
symmetri
mous
crystal
structur
dimer
similar
shape
bar
domain
bind
membran
gener
stabil
curvatur
ntermin
tail
could
bind
cytoplasm
bar
domain
protein
eg
enhanc
mechan
stabil
stabil
tabul
model
stabil
tubul
prevent
scission
model
mediat
inhibit
viral
bud
barlik
oligom
stabil
tubul
membran
prevent
membran
scission
tubul
could
stabil
cytosol
bar
domain
protein
bind
cytoplasm
tail
eg
hypothet
model
base
observ
barlik
dimer
mous
ectodomain
crystal
structur
observ
long
tubelik
structur
longer
ectodomain
tether
vlp
plasma
membran
cryoem
wwwadvancedsciencenewscom
wwwbioessaysjournalcom
like
rigid
rod
like
flexibl
rope
solut
like
aid
abil
adjust
dynam
viru
assembl
plasma
membran
ectodomain
also
contain
two
conserv
nlink
glycosyl
site
figur
appear
requir
proper
vesicular
transport
possibl
fold
requir
antivir
activ
although
isol
ectodomain
form
parallel
homodim
transmembran
region
also
form
parallel
dimer
lipid
environ
like
aid
format
parallel
dimer
collect
structur
featur
serv
inhibit
viral
bud
plasma
membran
bulk
evid
literatur
suggest
restrict
envelop
viru
releas
directli
bridg
host
viral
membran
simultan
inclus
two
oppos
membran
anchor
figur
cryoem
cryoet
studi
shown
bud
virus
vlp
anchor
cell
short
tether
contain
two
orient
viral
tether
possibl
figur
howev
insert
gpianchor
viral
membran
favor
threeto
fivefold
orient
would
optim
abil
ntermin
ct
interact
cytoskeleton
like
aid
cluster
host
membran
accumul
hiv
bud
site
cluster
around
four
seven
molecul
per
site
mutat
ectodomain
prevent
cluster
render
unabl
restrict
releas
vlp
orient
cluster
also
like
enhanc
abil
form
signal
complex
discuss
section
crystallograph
cryoem
studi
suggest
second
potenti
mechan
inhibit
viral
bud
analysi
crystal
structur
mous
reveal
dimerof
dimer
assembl
resembl
form
bar
domain
figur
bar
domain
bundl
dimer
form
crescentshap
structur
bind
stabil
curv
membran
form
membran
traffick
bud
event
cluster
could
form
assembl
could
stabil
cytosol
side
bardomain
protein
bind
ct
use
ctermin
domain
assembl
could
stabil
tubul
membran
prevent
viral
scission
figur
interestingli
cryoem
studi
hivinfect
cell
observ
tether
span
least
much
longer
singl
ectodomain
henc
lend
support
potenti
assembl
highli
effici
trap
wide
varieti
envelop
virus
consequ
virus
develop
countermeasur
evad
antivir
function
viral
antagonist
impair
number
differ
mechan
includ
remov
prevent
traffick
cell
surfac
target
proteosom
degrad
exampl
encod
vpu
small
membran
protein
interact
via
transmembran
region
vpu
facilit
recruit
ubiquitin
ligas
enabl
target
endolysosom
degrad
kshv
use
similar
strategi
encod
protein
ring
ubiquitin
ligas
recogn
ct
thu
enabl
ubiquitin
subsequ
degrad
siv
nef
protein
direct
remov
cell
surfac
bind
ct
link
endocyt
adaptor
remov
plasma
membran
env
protein
interact
ectodomain
likewis
facilit
intern
via
via
intern
motif
env
cytoplasm
tail
ebola
envelop
glycoprotein
gp
also
interact
ectodomain
howev
interact
appear
independ
protein
sequenc
also
requir
gp
transmembran
domain
lead
signific
surfac
remov
thu
virus
develop
myriad
method
inhibit
antivir
function
facilit
interact
involv
variou
structur
featur
protein
theme
virus
encod
antagonist
extend
respiratori
virus
figur
mention
earlier
iav
releas
appear
partial
restrict
straindepend
manner
differ
appear
mostli
due
variat
sequenc
encod
neuraminidas
neuraminidas
wide
report
iavencod
antagonist
littl
known
mechan
action
despit
lack
inform
differ
singl
amino
acid
report
switch
restrict
iav
vlp
one
inhibit
interact
appear
mediat
ectodomain
two
protein
howev
interact
appear
promot
surfac
remov
recent
studi
suggest
iav
channel
protein
antagonist
contrast
neuraminidas
interact
promot
surfac
remov
end
proteasom
degrad
addit
iav
encod
gener
ifni
antagonist
broadli
inhibit
express
isg
may
partial
inhibit
via
broadli
target
strategi
encod
v
protein
target
surfac
remov
appear
catalyz
proteasom
destruct
may
also
prevent
viralmedi
induct
sarscov
encod
bind
via
interact
ectodomain
interact
appear
inhibit
matur
glycosyl
prevent
surfac
express
infect
cell
promot
surfac
remov
mechan
viral
protein
involv
unknown
sev
infect
promot
proteasom
degrad
degrad
appear
mediat
fusion
f
hemagluttaninneuraminidas
hn
protein
concert
although
mechanist
detail
unknown
summari
respiratori
virus
also
evolv
countermeasur
inhibit
viral
tether
demonstr
evolutionari
pressur
evad
potent
viral
restrict
factor
known
role
inflammatori
signal
addit
function
viral
tether
protein
also
act
innat
immun
viral
sensor
signal
trigger
activ
elicit
product
inflammatori
cytokin
alert
neighbor
cell
extend
protect
abil
adjac
cell
induc
product
antivir
protein
cluster
captur
bud
virion
initi
assembl
signal
pathway
caus
activ
cluster
creat
format
special
signal
motif
call
hemitam
includ
residu
ct
recruit
srcfamili
kinas
becom
phosphoryl
figur
phosphoryl
specif
recruit
kinas
syk
assembl
signal
complex
compos
adaptor
well
culmin
downstream
activ
coupl
actin
cytoskeleton
via
interact
bar
rhogap
contain
protein
bind
ct
mutat
inhibit
interact
prevent
reduc
phosphoryl
subsequ
downstream
activ
thu
appear
preconcentr
cell
surfac
requir
effici
cluster
virus
signal
induc
express
inflammatori
antivir
signal
cytokin
virusencod
antagonist
vari
effect
activ
appear
link
abil
direct
degrad
vpu
target
surfac
remov
destruct
also
prevent
activ
howev
ebola
gp
env
engag
inhibit
viral
tether
abil
direct
degrad
inhibit
signal
abil
impact
antagonist
encod
respiratori
virus
activ
investig
also
implic
inhibitori
signal
plasmacytoid
dendrit
cell
pdc
therebi
dampen
inflammatori
signal
capac
serv
ligand
inhibitori
receptor
exclus
express
pdc
figur
circul
pdc
produc
ifni
respons
virusderiv
stimul
initi
antivir
state
infect
surround
cell
includ
upregul
express
express
infect
neighbor
cell
engag
surfac
pdc
signal
shut
product
ifni
negativefeedback
manner
prevent
overstimul
vpu
appear
exploit
mechan
specif
target
cluster
viral
bud
site
destruct
enrich
distribut
outsid
viral
bud
site
thu
enhanc
probabl
interact
suppress
pdc
antivir
respons
interact
also
suggest
occur
ci
express
surfac
pdc
possibl
prevent
prematur
matur
also
suppress
virusinduc
interferon
product
alter
innat
immun
signal
recent
report
direct
degrad
rigilik
receptor
mav
dampen
ifni
product
scenario
engag
mav
recruit
ubiquitin
ligas
direct
polyub
chain
mav
structur
domain
demonstr
mediat
direct
interact
indic
solid
red
arrow
impli
interact
denot
dash
red
arrow
antagon
iav
straindepend
strain
neuraminidas
protein
partial
inhibit
iav
releas
antagon
thought
mediat
ectodomain
ed
neuraminidas
anoth
studi
suggest
iav
antagon
use
hemagglutinin
effect
requir
neuraminidas
recent
studi
suggest
iav
channel
protein
antagon
target
interact
ectodomain
andor
transmembran
tm
caus
surfac
remov
cytoplasm
v
protein
may
antagon
two
differ
mechan
may
bind
target
surfac
remov
may
also
inhibit
induct
express
interact
mediat
unknown
sev
f
hn
protein
requir
degrad
howev
unknown
interact
mediat
mechan
sar
cov
ectodomain
mediat
interact
lead
inhibit
glycosyl
antagon
human
trigger
surfac
remov
ident
antagonist
protein
unknown
wwwadvancedsciencenewscom
wwwbioessaysjournalcom
polyubiquitin
engag
lead
autophag
degrad
figur
function
highlight
need
tight
regul
ifni
product
initi
proper
antivir
immun
respons
avoid
develop
autoimmun
disord
addit
role
signal
pathway
may
also
play
role
mediat
intercellular
signal
tether
exosom
exosom
small
secret
extracellular
vesicl
carri
cargo
growth
factor
cytokin
nutrient
cell
trap
exosom
surfac
parent
cell
therebi
control
whether
exosom
involv
shortor
longrang
commun
cell
first
identifi
potent
antivir
factor
decad
sinc
much
research
activ
antivir
immunolog
function
investig
demonstr
restrict
wide
varieti
envelop
virus
number
recent
studi
indic
also
restrict
bud
respiratori
virus
lead
phosphoryl
tyrosin
ydycrv
motif
cytoplasm
tail
srcfamili
kinas
follow
recruit
activ
syk
syk
activ
recruit
complex
lead
activ
nfkb
induct
proinflammatori
cytokin
upregul
express
surfac
infect
cell
engag
plasmacytoid
dendrit
cell
pdc
receptor
result
inhibitori
signal
reduc
express
ifn
pdc
also
neg
regul
rigilik
receptor
innat
immun
signal
rigi
recogn
uncap
viral
dsrna
induc
mav
result
ifni
express
subsequ
express
recruit
ubiquitin
catalyz
addit
polyub
chain
mav
chain
recogn
recruit
autophagosom
destruct
therebi
dampen
ifni
product
wwwadvancedsciencenewscom
wwwbioessaysjournalcom
exemplifi
fact
virus
develop
countermeasur
signific
pressur
could
function
exploit
clear
respiratori
viru
infect
knowledg
need
design
treatment
section
discuss
could
achiev
given
current
state
knowledg
examin
gap
need
address
nearli
envelop
virus
investig
date
encod
antagonist
least
partial
block
abil
prevent
viru
releas
theori
inhibit
antagonist
specif
disrupt
interact
would
allow
exert
function
cell
surfac
trap
virion
releas
concept
actual
least
experiment
antivir
function
antagon
vpu
investig
comprehens
understand
allow
design
uniqu
membranetarget
peptid
well
highthroughput
assay
identifi
compound
prevent
vpumedi
surfac
downregul
small
molecul
inhibit
releas
suppress
replic
similar
pursuit
could
engag
respiratori
virus
howev
similar
level
comprehens
knowledg
would
need
obtain
ident
antagonist
encod
variou
respiratori
virus
well
mechan
action
poorli
understood
action
establish
eg
rsv
emerg
respiratori
pathogen
eg
metapneumoviru
bocaviru
investig
addit
unknown
whether
exert
inhibitori
effect
toward
nonenvelop
virus
within
class
rhinoviru
promin
respiratori
pathogen
caus
sever
acut
diseas
trigger
asthma
exacerb
other
studi
tabl
detail
known
put
antagonist
engag
mechan
action
fact
viru
structur
detail
antagonist
action
elucid
vpu
detail
mechanist
structur
studi
antagonist
action
interact
requir
design
inhibitor
develop
screen
discov
addit
mechanist
studi
carri
airway
epitheli
cell
line
verifi
primari
airway
epitheli
cell
anim
model
treatment
would
virusspecif
current
knowledg
indic
respiratori
viru
employ
uniqu
antagonist
mechan
understood
play
role
innat
immun
downstream
inflammatori
signal
viral
cluster
initi
signal
cascad
result
activ
product
cytokin
involv
inflammatori
antivir
respons
figur
addit
serv
ligand
dampen
product
antivir
ifni
third
dampen
innat
immun
signal
mav
inhibit
aspect
may
need
creat
optim
tune
antivir
versu
antiinflammatori
respons
airway
although
mechanist
detail
known
three
pathway
detail
structur
biophys
inform
regard
interact
event
report
eg
engag
central
activ
bind
signal
downregul
ifn
product
detail
requir
develop
method
block
enhanc
interact
addit
current
unknown
whether
antagonist
encod
respiratori
virus
alter
signal
pathway
need
cell
surfac
order
restrict
viru
releas
suppress
infect
express
mostli
control
interferon
signal
howev
induct
also
report
absenc
ifn
suggest
multipl
transcript
factor
mayb
abl
regul
express
impli
pharmacolog
induct
independ
pleiotrop
effect
ifn
like
possibl
longterm
overexpress
implic
growth
progress
cancer
method
enhanc
surfac
express
approach
caution
howev
unclear
whether
enhanc
surfac
express
short
term
would
signific
risk
essay
present
first
comprehens
review
antivir
function
signal
respect
respiratori
virus
emerg
evid
indic
restrict
bud
replic
import
respiratori
virus
counteract
encod
viral
antagonist
detail
structur
biophys
cellular
immunolog
studi
util
airway
cell
need
develop
mechanist
understand
respiratori
virus
antagon
antivir
function
potenti
immunolog
signal
understand
could
lead
develop
novel
therapi
exploit
function
enhanc
recoveri
respiratori
viru
infect
bone
marrow
stromal
antigen
copd
chronic
obstruct
pulmonari
diseas
cryoem
cryoelectron
microscopi
cryoet
cryoelectron
tomographi
ergic
er
